Committee for Medicinal Products for Human Use (CHMP) has recommended an update to Novo Nordisk’s Wegovy (semaglutide 2.4 mg) ...

The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...

BAGSVAERD, Denmark I 19, 2024 I Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human ...

The company noted that Wegovy is the first obesity medication to receive a positive opinion recommending a label update that reflects reduced symptoms and improved physical limitations and exercise ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

those on Wegovy were 33 percent less likely to die of the illness than those who took the placebo. The findings were presented at the European Society of Cardiology (ESC) Conference 2024 in London ...

researchers said in a presentation at the European Association for the Study of Diabetes' annual meeting in Madrid. Related Study: Using Ozempic, Wegovy won't increase risk of depression ...

The early findings show a greater weight loss than those who took Wegovy during a similar time frame, who lost about 6%. The findings were presented at the European Association for the Study of ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments ...

The European Union is aiming to hold a vote to introduce definitive tariffs on electric vehicles imported from China on Sept.

European Union chief Ursula von der Leyen puts women in many of the top roles in her new Commission team BRUSSELS -- European Union chief Ursula von der Leyen puts women in many of the top roles ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month ... researchers said in a presentation at the European Association for the Study of Diabetes' ...